Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
US8263344B2 · kind B2 · utility
3Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 7, 2007 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Oct 10, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for determining the susceptibility of a patient tumor cell to a cancer treatment, which method comprises the detection or measure of CRT, KDEL receptor and/or ERp57 on the surface of a tumor cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.